💨 Abstract

United Therapeutics Corp. reported a profit of $322.2 million for the first quarter of 2025, exceeding Wall Street expectations with earnings of $6.63 per share. Revenue was also higher than anticipated at $794.4 million. The Silver Spring, Maryland-based drugmaker's results were compiled using data from Zacks Investment Research.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖